More than
More than
More than
decision models
More than
therapeutic areas
What we do

Qubists are a consulting firm offering services to smaller companies in the healthcare space and to investors who need expert knowledge on specific companies or products. Prior to 2018, we were operating as Hari Group.


We are a boutique consulting firm – we are small, focused and experts in what we do. As a policy, we do not take on projects from large pharma. It is too boring, and we just do not like slow decision making. We also believe that expertise matters, education is critical and the ability to connect the dots is what makes someone brilliant. Our consultants embody these principles. Qubists bring quanta of intelligence (Qubits) and dollops of creativity (Cubists) to work for you. Last but not the least, we believe that numbers are what matters in business. In healthcare, this applies to patients served, efficacy rates, survival rates, readmission rates, market shares, units sold, sales, value added etc., etc.. We do not do ‘QUALITATIVE MARKET RESEARCH’ since we believe any business decision that is not anchored in numbers is not worth making. If you come to us with your business or strategy need, we will propose a plan and methodology that will have a basis in measurable metrics.


We have the skills and resources to conduct market, product and service evaluations globally including the emerging markets. We have extensive experience in conducting global opportunity assessments and have helped large (in the past, but will not be doing this anymore), medium and small pharmaceutical, biotechnology and device companies around the world.


We have been in this space for over a decade and have conducted projects to support decisions around (a) funding for early stage companies, (b) advancing an asset across phases of clinical trials, (c) drug licensing opportunities, (d) valuation of revenue streams for monetization (e) pricing new products, (f) market scoping and (g) developing a viable target product profile. We have also developed forecasts for hundreds of new products, including valuations for many. We also develop health economic evaluations – patient level microsimulation models and Markov models – to support pricing and reimbursement.


We have processes in place to provide results very rapidly to our clients with most projects taking under 4 weeks from commissioning to delivery. With mission critical projects, we work out of client offices to reduce unnecessary back and forths, and time wasted on telephone calls.


We sell downloadable reports analyzing key events in the healthcare space which you can browse by clicking here. We add reports every other week – so please check regularly for new reports.


We sell downloadable epidemiology data for disease areas that are difficult to quantify which you can view by clicking here. We add data every other week – so please check regularly for new epi data.


We help you understand the potential of specific therapeutic areas, country markets, soon-to-be launched products and early stage molecules, including intellectual property. Our offerings are designed to maximize returns from your R&D, business development, licensing and marketing efforts.


We conduct primary market research, secondary research and data analysis to help develop strategy at the product and business level. We set up custom models for quantitative assessment of strategies, scenario analyses and development of strategic options. The information and analysis that we deliver along with our decision tools facilitate structured thinking and decision making.


We also run custom workshops and participate in on-site meetings as needed to provide support to clients during projects.


We are unique in having the processes and resources in place to provide rapid turnarounds with global projects. 


Typical services offered

TPP testing and optimization

Product positioning assessment

Product opportunity assessment

Product sales forecasting with dynamic models

ROI assessment of clinical studies

ROI assessment of potential new indications

ROI assessment of potential new formulations

ROI assessment of planned marketing campaigns

Price elasticity assessment by country

Pricing and reimbursement assessment by country

Pricing and reimbursement strategy development

Development of health economic models

Business case development - inlicensing/ outlicensing

Business case development - early stage products

Business case development - royalty stream investment opportunities

Generic opportunity assessment

Business strategy workshop

Portfolio strategy workshop

Disease area strategy workshop

Product strategy workshop

Services for entrepreneurs and university researchers

  If you are an entrepreneur looking to license out a patent from a university                         


  • We will help you value the patent or asset
  • We will help you structure a mutually beneficial deal with the university licensing office
  • We will support you in raising funding for you venture

  If you are a university researcher or a patent holder looking to commercialize your idea 


  • We will help you value the patent or asset
  • We will help you identify a suitable entrepreneur or CEO who can commercialize the patent or asset

Services for companies with products in clinical trials

  High level strategy check                                                                                                                


We will have a detailed discussion of your situation as a company and about your products in development (or in the market). Our aim will be to:

  • Understand your longer term plans with your company and for your products – and then understand your reasoning and motivations behind those plans
  • Find out what your current strategy is, with your company (business strategy) and your products (product strategy)
  • See if your business and product strategy match with your plans – whether the strategy you are deploying has a high chance of getting you to where you plan to be, including whether you are set up to execute on that strategy at the business and product level


If your business or product strategy does not match with your plans – we will organize a workshop at your offices during which we will develop a set of strategic options that could help you achieve your plans for the company and your products. The key assumptions underpinning these strategic options will be identified as well. Following this, we will help you pick a strategy that maximizes your company/ product value.

At the culmination of the project, you will be provided with a report that summarizes all the findings and our strategy recommendations. The report will also include a spreadsheet model that ties in all the key assumptions behind the strategy and provides a valuation for the company or product. This dynamic model will help prioritize the criticality of the assumptions based on their impact on overall value.

We will also send you a proposal on what we could do to strengthen the key assumptions around the strategy that is recommended.


  Product strategy check                                                                                                                    


  • We will organize a workshop at your offices with the aim of understanding the product strategy that is being implemented
  • During this session, we will check your assumptions behind the viability and value of your product – including the targeted markets, target product profiles, clinical comparator being considered, potential pricing and market access
  • We will identify assumptions that are weak and need to be confirmed


After the workshop, we will provide you with a report that summarizes our findings. The report will also include a spreadsheet model that ties in all the key assumptions behind the product strategy and provides a forecast and valuation for the product. This dynamic model will visualize the key assumptions based on their impact on product value. This can be used to understand the potential value of the product to a licensor or partner also.
Along with this, we will send you a proposal outlining how we could clarify and strengthen the weak assumptions that were identified and need to be confirmed.


  Valuation of asset for partnering or out-licensing                                                                      


We have a specific offering to help you with understanding the value of your asset in the context of partnering or out-licensing:

  • We will undertake secondary research to develop epidemiology and market sizing for your product
  • We will conduct cost effective primary research to test out your asset for its target product profile, potential uptake and use as well as likely pricing in the key markets of the US, EU and Asia
  • We will deliver a forecast and valuation model for your product that takes into account its market, potential peak share, uptake and likely pricing, as ascertained through primary and secondary research. This will also incorporate development costs, development timelines and potential marketing costs after launch.
  • We also offer partnering and out-licensing negotiation support – we will provide tools that help you evaluate different deal structures real time at the negotiating table, help your business development executive in understanding recent deals that took place in the therapeutic area and also have a key consultant available in person if needed, at negotiation meetings.

Focus areas